Careers

Diversity, Equity & Inclusion

Experience

Innovation

Interactive Maps

Locations

About

Pages

Meet our team of innovators
Ask us how we do it

Professionals

Insights

Services

Home | Thompson Hine LLP

Atlanta

Chicago

Cincinnati

Cleveland

Columbus

Dayton

Los Angeles

Minneapolis

New York

Washington, D.C.

The race for a vaccine for the new coronavirus means significant opportunities for life science and biotechnology companies through government contracts. Thompson Hine’s&nbsp;<a href="https://www.thompsonhine.com/professionals/purcell-jr-francis" target="_self" rel="noopener">Chip Purcell</a> and&nbsp;<a href="https://www.thompsonhine.com/professionals/mason-tom" target="_self" rel="noopener">Tom Mason</a> discuss the government agencies seeking industry support and key issues for potential contractors. <a href="https://news.bloomberglaw.com/health-law-and-business/insight-coronavirus-vaccine-efforts-spur-contracts-for-life-science-biotech-companies" target="_self" rel="noopener">Read more</a>.

contentpilot/introduction

Partner

Tom Mason

Francis E. Purcell, Jr.

COVID-19 Task Force

Life Sciences

Government Contracts

INSIGHT: Coronavirus Vaccine Efforts Spur Contracts for Life Science, Biotech Companies